FDA Clearance Tracker · P100047-S077
HEARTWARE LEFT VENTRICULAR ASSIST SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 13, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2016
Approved
Time to decision
179 days
Received Jun 17, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100047-S077
- Device name
- HEARTWARE LEFT VENTRICULAR ASSIST SYSTEM
- Applicant
- Medtronic
- Applicant location
- Mounds View, MN
- Received
- Jun 17, 2016
- Decided
- Dec 13, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100047
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for print changes, content revision and the addition of an alternate manufacturer for the HeartWare Ventricular Assist System (HVAS) Patient Manual, Instructions for Use and Emergency Responders Guide.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.